2.09
-0.01 (-0.48%)
2.09
0 (0%)
ChartMill assigns a Buy % Consensus number of 87% to REPH. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 5.1. This target is 144.02% above the current price.
REPH was analyzed by 9 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about REPH.
In the previous month the buy percentage consensus was at a similar level.
REPH was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2021-10-12 | William Blair | Initiate | Outperform |
RECRO PHARMA INC / REPH FAQ
What is the price target for REPH stock?
9 analysts have analysed REPH and the average price target is 5.1 null. This implies a price increase of 144.02% is expected in the next year compared to the current price of 2.09.
Can you provide the consensus rating for RECRO PHARMA INC stock?
The consensus rating for RECRO PHARMA INC (REPH) is 86.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed RECRO PHARMA INC (REPH)?
The number of analysts covering RECRO PHARMA INC (REPH) is 9.